Dr. Gareth J. Morgan says new drugs are helping people with myeloma to live with good quality of life.
Photo: Andrew Lichtenstein/Getty
Advances in the treatment of multiple myeloma are enabling people who receive a diagnosis of this disease to live 10 years or longer. ѵ 60 percent of people are stable with good quality of life by the second or third year of remission, says Gareth J. Morgan, MD, PhD, director of multiple myeloma research at NYU Langone Health’s Perlmutter Cancer Center. Dr. Morgan discusses his approach to caring for people in remission and more on Patient Power’s Answers Now series.
“I like to make friends with the patients, bonding with them so they understand that they’ve got somebody that’s on their side, and then helping them to understand that they can have long periods of good-quality remission,” says Dr. Morgan, professor in the at NYU Grossman School of Medicine. “As long as they’re in a remission, they’ve got another year ahead of them.”
Watch more from .
